Patent details

Herbas

VPB

Print

EN | LT

LT - ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA

EN - ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 9/20
		A61K 31/437

European patent
(11)	Number of the document	3416627
(13)	Kind of document	T
(96)	European patent application number	18718476.7
	Date of filing the European patent application	2018-04-25
(97)	Date of publication of the European application	2018-12-26
(45)	Date of publication and mention of the grant of the patent	2019-11-27
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/EP2018/060547
	Date	2018-04-25

PCT application publication
(87)	Number	WO 2018/197538
	Date	2018-11-01

Priority applications
(30)	Number	Date	Country code
	17168281	2017-04-26	EP

Inventors
(72)	SCHWARZ, Franz Xaver, AT

Grantee
(73)	Sandoz AG, Lichtstrasse 35, 4056 Basel, CH

Title
(54)	ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA
	ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA